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Clean and Fast Amide Couplings in Water
Nicklas Buchbinder, Sudripet Sharma, Sachin Handa 
Department of Chemistry, University of Louisville, Louisville, KY 40292
Amide couplings are highly important to the pharmaceutical
industry.1 Presented is a methodology for amide couplings in water
with a fast reaction rate using EDC as a coupling reagent and PS-
750 M in water as a reaction medium. The reactions complete in 15-
45 min, where the product precipitates out and can be isolated via
simple filtration. It is an organic solvent-free and cost-effective
approach towards amide bond forming reactions.2
Introduction
EDC ((1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide) is a
carbodiimide that is well known reagent for the amide coupling
reactions between an amine and carboxylic acid in the presence of
a base. It is the commonly used coupling agent in industries
because it produces a water-soluble urea byproduct, which can be
easily removed by an aqueous work-up. However, our methodology,
the desired amide product precipitates out of the reaction mixture,
and no additional work-up is required.3 Using aqueous micelles of
PS-750-M as a solvent dramatically increases the rate of reaction.2
The filtrate recovered can be recycled to perform several coupling
runs after post-reaction manipulation.
EDC-Mediated Amide Couplings in Water
Conditions: Amine (0.25 mmol), carboxylic acid (.25 mmol), EDC•HCl (0.32 mmol), pyridine (0.5 mmol), 0.5 mL 3 wt % PS-
750-M in H2O, 60
o C, 10-45 min. The coupling reaction was performed on small scale as well as on gram scale to prove the
scalability. HPLC studies concluded that there was no racemization occurring within mmol or gram scales.2
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1. Lidocaine is used as a local anesthetic and has also proven useful as
both diagnostic and therapeutic medicine.4 The drug has found
successful at easing pain and avoiding drug-drug interactions.5
2. Bupivacaine is also used an anesthetic that is commonly used in
surgery. Epidural administration has proven to be an effective method for
longer and less toxic pain relief in patients.6 The drug has proven to
reduce the need for addictive postoperative narcotics when intra-articular
administration was used.7
3. Prilocaine is yet another anesthetic and has proven more useful than
Lidocaine in shorter surgeries. Epidural administration is used for short
term local anesthetic.8 and as pain relief cream with various
applications.9
4. Articaine is a local anesthetic used mostly in dental procedures.
Articaine is non-toxic with a shorter half-life than other anesthetics.10
5. Etidocaine is longer acting local anesthetic, that is metabolized less
quickly.11 This drug has also proved to act faster than most other
anesthetics.12
6. Lenalidomide is an immunomodulatory agent with anticancer
properties. It is commonly used to treat multiple myeloma.13 The drug has
proven very successful in reversing the effects of myelodysplastic
syndrome in the 5q31 deletion.14
7. Rivaroxaban is a direct factor Xa inhibitor that is used to prevent
venous thromboembolism (VTE) in adult patients. The drug can be
administered orally and seem to beneficial to patients regardless of age,
gender or weight.15
8. Sulfacetamide is an antibacterial medicine. It is commonly
administered with eye drop solutions as it boasts low toxicity.16
9. Chlorthalidone is a diuretic that is used to treat hypertension.
Chlorthalidone can significantly lower risks for stroke, coronary artery
disease and death.17
10. Lisdexamfetamine is used to treat attention deficit order. It is proven



























































amine + acid + EDC + base
(soluble in aq. PS-750-M)
urea = byproduct of EDC
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